Internal Medicine · Bonita Springs, FL
NPI
1649465378
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8800 Terrene Ct, Suite 102
Bonita Springs, FL, 34135
Phone (239) 948-3444
Groups this clinician bills Medicare through
Medicare paid, 2024
$752K
51,322 services
Medicare patients, 2024
960
Average age 78
Drug cost, 2024
$1.8M
14,081 prescriptions
Company payments, 2025
$1,098
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ziad Shahla was code J1071 (injection, testosterone cypionate, 1 mg), 36,916 times for 27 patients. In total Ziad Shahla billed 51,322 services in 79 codes, and Medicare paid $752K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 36,916 | 27 | $0.02 | $698 |
| 99214 Office E&M - Established | Office | 3,915 | 850 | $98.38 | $385K |
| J0897 Injection, denosumab, 1 mg | Office | 2,820 | 36 | $19.62 | $55K |
| 36415 Venipuncture Blood Collection | Office | 1,012 | 500 | $8.65 | $8,754 |
| 96372 Injection Administration | Office | 911 | 143 | $11.16 | $10K |
| 99215 Office E&M - Established | Office | 866 | 489 | $136.21 | $118K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 697 | 116 | $0.89 | $622 |
| 81002 Clinical Chemistry | Office | 398 | 326 | $3.41 | $1,357 |
| 93000 Electrocardiogram | Office | 377 | 344 | $10.59 | $3,994 |
| 85610 Clinical Chemistry | Office | 345 | 31 | $4.20 | $1,449 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 318 | 76 | $0.73 | $231 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 276 | 276 | $141.03 | $39K |
| 90662 Vaccine Product | Office | 211 | 204 | $80.74 | $17K |
| G0008 Administration of influenza virus vaccine | Office | 210 | 203 | $32.91 | $6,911 |
| 99213 Office E&M - Established | Office | 185 | 63 | $73.57 | $14K |
By year: 2022 $684K for 26,576 services; 2023 $719K for 42,589 services; 2024 $752K for 51,322 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,012 | 500 | $8.65 | $8,754 |
| 81002 Clinical Chemistry | 398 | 326 | $3.41 | $1,357 |
| 85610 Clinical Chemistry | 345 | 31 | $4.20 | $1,449 |
| 82570 Clinical Chemistry | 141 | 137 | $5.08 | $716 |
| 82044 Clinical Chemistry | 138 | 136 | $6.11 | $843 |
| 83036 Blood Count | 70 | 53 | $9.52 | $666 |
Medicare prescription drug claims, 2024
In 2024, the drug Ziad Shahla prescribed most often to Medicare patients was Amlodipine Besylate, with 1,048 prescriptions and refills. In total Ziad Shahla wrote 14,081 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,048 | 2,943 | 306 | $7,377 |
| Rosuvastatin Calcium Generic | 856 | 2,461 | 264 | $14K |
| Atorvastatin Calcium Generic | 761 | 2,204 | 220 | $6,874 |
| Levothyroxine Sodium Generic | 642 | 1,864 | 178 | $6,420 |
| Metoprolol Succinate Generic | 499 | 1,471 | 151 | $9,768 |
| Pantoprazole Sodium Generic | 405 | 1,153 | 139 | $6,292 |
| Metformin Hcl Generic | 280 | 759 | 87 | $2,034 |
| Mounjaro Tirzepatide | 257 | 324 | 37 | $336K |
| Gabapentin Generic | 253 | 606 | 90 | $5,494 |
| Ozempic Semaglutide | 251 | 312 | 46 | $282K |
| Tamsulosin Hcl Generic | 249 | 713 | 82 | $3,925 |
| Losartan Potassium Generic | 245 | 717 | 73 | $3,004 |
| Prednisone Generic | 244 | 383 | 132 | $1,466 |
| Olmesartan Medoxomil Generic | 226 | 643 | 71 | $4,385 |
| Eliquis Apixaban | 212 | 485 | 63 | $277K |
Brand drugs: 1,987 claims; generic drugs: 12,058 claims; opioid claims: 201.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ziad Shahla $1,098 ($1,098 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $309.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $309 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $208 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $163 |
| Lundbeck LLC | 4 | $117 |
| Amgen Inc. AMGN | 5 | $102 |
| Esperion Therapeutics, Inc. ESPR | 3 | $56.43 |
| Pfizer Inc. PFE | 2 | $41.06 |
| GlaxoSmithKline, LLC. GSK | 2 | $39.56 |
| CVRx, Inc. CVRX | 1 | $28.65 |
| Merck Sharp & Dohme LLC MRK | 1 | $16.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.